Dopamine receptors: from structure to behavior
- PMID: 11052218
- DOI: 10.1016/s1471-1931(00)00025-2
Dopamine receptors: from structure to behavior
Abstract
The responses obtained with drugs that act at dopamine receptors depend on the spectrum of receptors stimulated, the pattern of stimulation and the neuronal signal-transduction pathways that are activated. In the absence of drugs that reliably discriminate between the various cloned receptors, elucidating the role of these receptors has largely relied on molecular genetic approaches that include expression of genes for receptors in cell lines and manipulation of this expression in animal models. Connecting molecular events that occur consequent to receptor stimulation with the resulting physiological effects entails bridging a complex network of interactions. This article reviews the current understanding of the molecular, cellular and systemic consequences of activation of the different dopamine receptors.
Similar articles
-
Dopamine receptors and locomotor responses: molecular aspects.Ann Neurol. 2000 Apr;47(4 Suppl 1):S12-9; discussion S19-21. Ann Neurol. 2000. PMID: 10762128 Review.
-
Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.Can J Neurol Sci. 1992 Feb;19(1 Suppl):147-52. Can J Neurol Sci. 1992. PMID: 1349263 Review.
-
Molecular effects of dopamine on striatal-projection pathways.Trends Neurosci. 2000 Oct;23(10 Suppl):S64-70. doi: 10.1016/s1471-1931(00)00019-7. Trends Neurosci. 2000. PMID: 11052222 Review.
-
L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.Cereb Cortex. 2016 Oct 17;26(11):4253-4264. doi: 10.1093/cercor/bhw263. Cereb Cortex. 2016. PMID: 27613437 Free PMC article.
-
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats.Neurosci Res. 2017 Sep;122:45-50. doi: 10.1016/j.neures.2017.04.003. Epub 2017 May 31. Neurosci Res. 2017. PMID: 28577977
Cited by
-
Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement.Cell Mol Neurobiol. 2008 Feb;28(2):157-72. doi: 10.1007/s10571-007-9240-3. Epub 2007 Nov 28. Cell Mol Neurobiol. 2008. PMID: 18041576 Free PMC article. Review.
-
Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats.Neuropharmacology. 2011 Feb-Mar;60(2-3):284-94. doi: 10.1016/j.neuropharm.2010.09.011. Epub 2010 Sep 17. Neuropharmacology. 2011. PMID: 20850462 Free PMC article.
-
Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.Neuropharmacology. 2016 Sep;108:403-14. doi: 10.1016/j.neuropharm.2016.05.002. Epub 2016 May 6. Neuropharmacology. 2016. PMID: 27163190 Free PMC article.
-
Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase.J Biol Chem. 2008 Dec 26;283(52):36441-53. doi: 10.1074/jbc.M805520200. Epub 2008 Nov 4. J Biol Chem. 2008. PMID: 18984584 Free PMC article.
-
Cholestasis and behavioral disorders.Gastroenterol Hepatol Bed Bench. 2021 Spring;14(2):95-107. Gastroenterol Hepatol Bed Bench. 2021. PMID: 33968336 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical